progscrape: nejm.org

The Moderna COVID-19 vaccine is safe and efficacious in adolescents according to a new study based on Phase 2/3 data published in The New England Journal of Medicine

3 years ago nejm.org covid vaccine

Dietary salt substitute reduces heart disease deaths and all-cause mortality - a cluster-randomized trial of subjects aged over 60 with high blood pressure, or a history of stroke

3 years ago nejm.org disease trial

Researchers have successfully developed a 'speech neuroprosthesis' that has enabled a man with severe paralysis to communicate in sentences, translating signals from his brain to the vocal tract directly into words that appear as text on a screen.

3 years ago nejm.org brain

A blood marker predicts who gets ‘breakthrough’ COVID | NEJM

3 years ago nejm.org covid

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | NEJM

3 years ago nejm.org covid

Researchers develop technology to decode speech from cerebral cortical activity

3 years ago nejm.org

A new era for medicine: successful, first of its kind, CRISPR-Cas9 gene editing in people with ATTR amyloidosis

4 years ago nejm.org

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM

4 years ago nejm.org covid vaccine

Trial of Psilocybin versus Escitalopram for Depression | NEJM

4 years ago nejm.org psilocybin trial

Trial of Psilocybin versus Escitalopram for Depression

4 years ago nejm.org psilocybin trial